Has Dale Vincent, APRN received payments from drug or device companies?

Yes. Drug and device makers reported $28,317 in general payments to Dale Vincent, APRN across 383 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Dale Vincent, APRN did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Dale Vincent, APRN come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Dale Vincent, APRN

Family · Bardstown, KYNPI 1205164936

Payments from drug & device makers

$28,317in general payments, 2019–2025

Across 383 payments — averaging $73.93 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Karyopharm Therapeutics Inc.$17K
TG Therapeutics, Inc.$3K
AbbVie$572
Johnson & Johnson$532
AstraZeneca$518
Novartis$470
plus $6K from 54 others

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Karyopharm Therapeutics Inc.	26	$17,300
TG Therapeutics, Inc.	6	$3,068
AbbVie	24	$572
Johnson & Johnson	21	$532
AstraZeneca(2 entities)	22	$518
Novartis	21	$470
Gilead	23	$435
Merck	23	$430
Daiichi Sankyo Inc.	16	$420
E.r. Squibb & Sons, L.L.C.	19	$392
Incyte Corporation	9	$378
Pfizer	17	$324
Bristol Myers Squibb	13	$274
Regeneron Healthcare Solutions, Inc.	9	$241
Seagen Inc.	8	$196
Takeda Pharmaceuticals U.S.A., Inc.	8	$185
Genentech USA, Inc.	8	$180
EMD Serono, Inc.	4	$144
Beigene USA, Inc.	3	$130
ADC Therapeutics America, Inc.	5	$126
GSK	6	$115
Sanofi	5	$107
Ipsen Biopharmaceuticals, Inc	5	$99
Genmab U.S., Inc.	4	$90
Kyowa Kirin, Inc.	4	$85
Sumitomo Pharma America, Inc.	3	$83
Stemline Therapeutics Inc.	4	$83
Puma Biotechnology, Inc.	4	$69
Pharmaessentia USA Corporation	3	$64
Astellas Pharma US Inc	3	$64
Blueprint Medicines Corporation	2	$63
Array Biopharma Inc	4	$61
Mirati Therapeutics, Inc.	3	$61
Taiho Oncology, Inc.	2	$58
Boehringer Ingelheim	2	$55
Pharmacyclics LLC, An Abbvie Company	3	$52
Adaptive Biotechnologies Corporation	3	$51
Bayer	2	$50
Coherus Oncology, Inc.	2	$49
Jazz Pharmaceuticals Inc.	3	$47
Sobi, Inc	2	$42
Legend Biotech USA Inc.	1	$41
Tersera Therapeutics LLC	2	$40
Lilly USA, LLC	2	$38
Pharmacosmos Therapeutics Inc.	2	$38
Cumberland Pharmaceuticals, Inc.	2	$34
Iovance Biotherapeutics, Inc.	1	$34
Beone Medicines USA, Inc.	1	$33
CTI Biopharma Corp.	2	$31
AVEO Pharmaceuticals, Inc.	2	$30
Alnylam Pharmaceuticals Inc.	1	$24
Sun Pharmaceutical Industries Inc.	1	$23
Deciphera Pharmaceuticals Inc.	1	$22
Accord Healthcare, Inc.	1	$21
G1 Therapeutics, Inc.	1	$20
Fennec Pharmaceuticals, Inc.	2	$19
Secura Bio, Inc.	1	$18
Eisai Inc.	1	$17
Rigel Pharmaceuticals, Inc.	1	$16
Agios Pharmaceuticals, Inc.	1	$16

How this compares

$28,317 in reported general payments places this provider in the 95th percentile of 4,374 family providers in Kentucky.

See all family providers in Kentucky →

Medicare billing

Part B allowed, 2024

$34,985

Medicare patients

224

Services billed

450

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other family in Bardstown

Bonnie HillLouisa$372K
Ashley SnellenElizabethtown$190K
Smita RanjanLouisville$92K
Elizabeth SaltLexington$89K
Tracey GaslinLouisville$79K
Kassandra GreenLouisville$69K
Danielle RevertLouisville$65K
Lora BrownMonticellow$61K
Shelley WaldmanLouisville$59K
Vicki ChapmanMount Vernon$57K

See the full list for Kentucky →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →